• About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q3 2020

  • November 23, 2020
  • Industry Updates
  • Healthcare, Medical Technology
Share on facebook
Share on twitter
Share on linkedin
Featured Pulse Med Q1 2020
Medical Technology: Searching For Stability In The New Normal
  • 2020 has been a year like no other! In the center of it all medical equipment and consumable manufacturers, diagnostic test providers, and pharmaceutical/biotechnology developers have been working tirelessly in the effort to combat COVID-19. In addition to helping treat those who have contracted COVID-19, these companies have also been critical players in the push to develop and manufacture massive numbers of diagnostic tests, as well as to test and validate potential vaccines for the disease.
  • Like nearly all publicly traded U.S. equities, the stock performance of PMCF’s four Medical Technology indices turned negative during the spring months, with a rapid decline in valuations, followed by varying levels of recovery and growth. Aside from the Orthopedic Medical Device index, a sector particularly challenged by the effects of COVID-19 related shutdowns, the other indices outperformed the Dow Jones Industrial Average over the last twelve months but underperformed the S&P 500 Growth Index.
  • While PMCF’s Medical Technology indices reacted sharply to previous COVID-19 milestones and events, the likely effect of the recent second wave spike in cases and vaccine data readouts remains unclear.

 

PMCF-Pulse-Medical-Technology-2020-Q3

File size: 2.02 MB
Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Plastics & Packaging M&A Update – November 2020
Industrial Distributor M&A Pulse – Q3 2020
Food & Beverage M&A Pulse – Q3 2020
Plastics & Packaging M&A Update – October 2020
Medical Technology M&A Pulse – Q3 2020
Contact

Follow Us On

Securities offered through P&M Corporate Finance, LLC. Member of FINRA and SIPC.

blank
Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

M&A Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

©2020 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​
Cookie Notice: This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our Privacy Policy for more information on the cookies we use.AgreePrivacy policy